GO
Loading...

Enter multiple symbols separated by commas

Bombs In The Portfolio

webxtra_thumb.jpg

In Wednesday’s Web Extra, hedge fund manager Whitney Tilson reveals how he’s playing Ambac and MBIA. Will the companies bounce or are they toxic?

This content is only available online - you won't find these trades on TV.

______________________________________________________
Got something to say? Send us an e-mail at fastmoney-web@cnbc.com and your comment might be posted on the Rapid Recap! Prefer to keep it between us? You can still send questions and comments to fastmoney@cnbc.com.

Trader disclosure: On Jan 16, 2008, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Macke Owns (INTC), (YHOO); Najarian Owns (C), (CSCO), (BIIB), (FRE),(MCD), (TIBX); Najarian Owns (AAPL) Options, (YHOO) Options, (WM) Options; Finerman's Firm And Finerman Own (CROX); Finerman Owns (GS), (TSO), (VLO), (WMT), (YHOO); Finerman's Firm Owns (MS) Options; Finerman's Firm Owns (MSFT) Options; Finerman's Firm Owns (MDY) Puts And Is Short (MDY); Finerman's Firm Owns Russell 2000 Puts And Is Short (IWM); Finerman's Firm Owns S&P 500 Puts And Is Short (SPY); Finerman's Firm Is Short (IJR), (IYR); Finerman's Firm Is Short (LEH) And Owns (LEH) Puts; Tilson's Funds Own Berkshire Hathaway, Tilson's Funds Are Short (LEH); Tilson's Funds Own (SHLD), (BGP), (BKS)

Contact Fast Money

  • Showtimes

    Halftime Report - Weekdays 12p ET
    Fast Money - Weekdays 5p ET

Subscribe

Halftime Report

  • A Marathon gas station in Chicago.

    CNBC "Halftime Report" trader Jim Lebenthal is buying an energy stock he believes will move higher regardless of the direction of oil prices.

  • How should you China-proof your portfolio?

    Sarat Sethi, Douglas C. Lane & Associates, and the "Fast Money Halftime Report" panel discuss how to play China.

  • Top holdings in health care: Pro

    Discussing the latest pharma news making headlines including Teva's $40.5 billion deal and health care picks that show opportunity with Sam Isaly, OrbiMed Advisors founder.